A carregar...
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
The primary objective of this trial was to establish the maximum tolerated dose (MTD) of oxaliplatin 130 mg/m(2) preceded by escalating doses of docetaxel 60 mg/m(2) (75, 90, 100 mg/m(2)) administered every 3 weeks. A total of 11 patients were entered; 10 evaluable for response: 4 stable disease (li...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3779138/ https://ncbi.nlm.nih.gov/pubmed/23712328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2171-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|